Inter & Co: Strong Fundamentals Despite Market Fluctuations
Finance

Inter & Co: Strong Fundamentals Despite Market Fluctuations

authorBy Nouriel Roubini
DateAug 10, 2026
Read time2 min

Inter & Co, Inc. (INTR) is showcasing a robust resurgence in client acquisition and average revenue per active customer (ARPAC) during the second quarter, despite a substantial decline in its stock value over the past six months. The company's recent performance highlights significant operational improvements, including adding 1.3 million net customers and achieving a 15% year-over-year customer growth. Furthermore, the Return on Equity (ROE) has improved to 16.3%, nearing a crucial 'rule of 50' benchmark.

While Inter & Co's credit portfolio continues to expand, there's an acknowledgment of an increase in Non-Performing Loans (NPLs) to 5.3%, especially within the Private Payroll segment. This rise in NPLs points to broader macroeconomic pressures and specific product-related risks. However, the current valuation of INTR stock, trading at approximately 5.5 times its estimated 2027 earnings, suggests a highly favorable risk-reward balance. This presents an attractive opportunity for investors, as the underlying business fundamentals continue to strengthen.

Inter & Co's ability to drive customer growth and enhance profitability amidst market volatility demonstrates its resilience and strategic effectiveness. The company’s continued focus on core operations and its attractive valuation make it a compelling proposition for long-term investors. Despite current market sentiment, the improving metrics indicate a positive trajectory, promising a bright future for the company and its stakeholders.

More Articles
Finance
The ONE Group Hospitality: A Restaurant Stock with Growth Potential
The ONE Group Hospitality, Inc. (STKS) showcased significant operational improvements in Q2 2026, with comparable sales rising by 0.9% and positive customer traffic across all segments, indicating market share expansion. Despite revenue impacts from strategic closures, procurement efficiencies led to a 110 basis point increase in restaurant margins. The company's shift towards asset-light development and Benihana Express units is boosting cash flow and debt reduction, making its valuation increasingly attractive.
By Nouriel RoubiniAug 10, 2026
Finance
Lazard Developing Markets Equity Portfolio's Q2 Outperformance
The Lazard Developing Markets Equity Portfolio recorded a strong performance in the second quarter, surpassing its benchmark, the MSCI Emerging Markets Index. The portfolio's institutional shares climbed by 30.4%, notably higher than the index's 24.1% gain. This success was primarily fueled by strategic stock selections within the information technology and consumer staples sectors, particularly in key markets like China and Korea. The broader emerging markets landscape experienced significant growth, largely driven by the burgeoning artificial intelligence sector and a reduction in geopolitical tensions.
By Robert KiyosakiAug 10, 2026
Finance
Understanding Money Orders: A Comprehensive Guide
Money orders provide a secure and straightforward method for making payments, especially beneficial for individuals without traditional checking accounts. This guide offers detailed instructions on when to utilize money orders, how to accurately complete them, and where to acquire them. It also highlights the advantages and disadvantages of using money orders, along with procedures for cancellation or replacement, ensuring a clear understanding of this financial tool.
By Michele FerreroAug 10, 2026
Finance
Permian Resources' Strategic Rollup: A Blueprint for Oil and Gas Growth
Permian Resources (PR) is implementing a disciplined acquisition strategy, focusing on small, undervalued bolt-on assets. This approach has led to significantly lower average acquisition costs compared to competitors, enabling the company to build valuable contiguous land blocks. These strategic acquisitions are enhancing PR's capital returns and overall profitability throughout various market cycles.
By Fareed ZakariaAug 10, 2026
Finance
Veracyte's Genomic Tests Propel Growth and Future Potential
Veracyte (VCYT) is an oncology diagnostics company specializing in genomic testing for various cancers. Their key tests, Decipher and Afirma, are consistently achieving double-digit growth and improving profit margins. This strong performance positions VCYT as a potential long-term cash flow generator. Additionally, their newer offerings, Prosigna and TrueMRD, provide further long-term growth opportunities, which are not yet fully reflected in management's 2026 revenue projections. Given these factors, VCYT's current valuation appears reasonable, offering attractive upside potential.
By Lisa JingAug 10, 2026